↓ Skip to main content

A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice

Overview of attention for article published in Frontiers in Pharmacology, May 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice
Published in
Frontiers in Pharmacology, May 2023
DOI 10.3389/fphar.2023.1204905
Pubmed ID
Authors

Jade Gauvin, Geneviève Frégeau, Hanan Elimam, Liliane Ménard, David Huynh, Catherine Lê, Ahsanullah Ahsanullah, William D. Lubell, Huy Ong, Sylvie Marleau

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 67%
Student > Bachelor 1 33%
Readers by discipline Count As %
Agricultural and Biological Sciences 1 33%
Medicine and Dentistry 1 33%
Unknown 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2023.
All research outputs
#15,562,959
of 23,901,621 outputs
Outputs from Frontiers in Pharmacology
#5,669
of 17,570 outputs
Outputs of similar age
#93,385
of 194,052 outputs
Outputs of similar age from Frontiers in Pharmacology
#54
of 427 outputs
Altmetric has tracked 23,901,621 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,570 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,052 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 427 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.